RAB0520
Bovine IFNG / Interferon Gamma ELISA Kit
for serum, plasma and cell culture supernatants
Sign Into View Organizational & Contract Pricing
Select a Size
96 WELLS
$569.00
$569.00
Usually ships in 1 week. (Orders outside of US and Europe, please allow an additional 1-2 weeks for delivery)
All Photos(1)
Select a Size
Change View
96 WELLS
$569.00
About This Item
UNSPSC Code:
41116158
NACRES:
NA.32
$569.00
Usually ships in 1 week. (Orders outside of US and Europe, please allow an additional 1-2 weeks for delivery)
Recommended Products
species reactivity
bovine
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
input
sample type cell culture supernatant(s)
sample type serum
sample type plasma
assay range
inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 0.11 ng/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
bovine ... IFNG(281237)
General description
This ELISA antibody pair detects bovine Interferon Gamma.
Application
For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Other Notes
A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.
Please type the word sample in the text box provided for lot number.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
Storage Class
8A - Combustible corrosive hazardous materials
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Janyra A Espinoza et al.
Journal of immunology (Baltimore, Md. : 1950), 199(1), 212-223 (2017-06-02)
Human respiratory syncytial virus (hRSV) is the leading cause of severe lower respiratory tract infections in children. The development of novel prophylactic and therapeutic antiviral drugs against hRSV is imperative to control the burden of disease in the susceptible population.
Kawaljit Kaur et al.
Oncoimmunology, 7(5), e1426518-e1426518 (2018-05-04)
Therapeutic role of NK cells in solid tumors was challenged previously even though their role in hematological malignancies has clearly been established. Furthermore, functions and numbers of NK cells are greatly suppressed in oral cancer patients necessitating effective future NK
Greta Garrido et al.
Frontiers in pharmacology, 8, 595-595 (2017-10-24)
Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor - T cell interactions. Previous studies showed an
Krithika N Kodumudi et al.
Frontiers in immunology, 10, 1939-1939 (2019-09-03)
Patients with metastatic HER2 breast cancer (MBC) often become resistant to HER 2 targeted therapy and have recurrence of disease. The Panacea trial suggested that HER2 MBC patients were more likely to respond to checkpoint therapy if TIL were present
Guanghui Zhao et al.
Acta tropica, 171, 17-23 (2017-02-28)
Aspartic proteases in the Toxoplasma gondii, called TgASP1, 2, 3, and 5, play essential roles in the life cycle. In a previous study, we have demonstrated that TgASP1 is an antigen that prolongs survival time of infected mice. As an
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
